SPRINT — Sprint Bioscience AB Share News
0.000.00%
Last trade - 00:00- SEK469.54m
- SEK361.22m
- SEK167.17m
Brief: Sprint Bioscience AB - Appoints Mathias Skalmstad As CFO
Brief: Sprint Bioscience Carries Out Private Placement Of SEK 20.7 Mln
Brief: Sprint Bioscience License Partner Sells Petra01-Project To Hibercell
Brief: Sprint Bioscience Appoints New CEO
Brief: Sprint Bioscience Awarded Patent For Vps34 In Taiwan, Hong Kong
Brief: Sprint Bioscience Q4 Operating Loss Widens To SEK 13.0 Mln
Brief: Sprint Bioscience Gets Information About Approval Of Patent In Australia And Hong Kong
Brief: Sprint Bioscience Names Patrik Fagerholm Interim CFO
Brief: Sprint Bioscience CEO Resigns, Co Appoints Acting CEO
Brief: Sprint Bioscience Q2 Operating Result Swings To Loss SEK 10.1 Million
Brief: Sprint Bioscience CFO Resigns
Brief: Sprint Bioscience Rights Issue Gets Oversubscribed
Brief: Sprint Bioscience AB - Outcome Of Exercise Of Warrants Of To 2 Series
Brief: Sprint Bioscience To Get Two Patents For Vps34-Inhibitors
Brief: Sprint Bioscience To Carry Out Rights Issue Of Units Of SEK 48.5 Million
Brief: Sprint Bioscience Q1 Operating Loss Widens To SEK 9.5 Million
Brief: Sprint Bioscience Announces Identity Of Target Protein In Project VADA
Brief: Sprint Bioscience To Carry Out Rights Issue Of Units
Brief: Sprint Bioscience Decides To Apply For Short Term Work For Co's Employees